Hill, Michael P <br/><br/>
Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Jul 2004 
 - 386-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.104.066191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amantadine--therapeutic use<br/>Animals<br/>Anticonvulsants--therapeutic use<br/>Antiparkinson Agents--therapeutic use<br/>Callithrix<br/>Disease Models, Animal<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Dyskinesias--drug therapy<br/>Female<br/>Levetiracetam<br/>Levodopa--therapeutic use<br/>MPTP Poisoning--drug therapy<br/>Male<br/>Piracetam--analogs & derivatives